Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.7201
-0.4099 (-36.27%)
At close: Jun 27, 2025, 4:00 PM
0.7769
+0.0568 (7.89%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $23.40 million as of June 27, 2025. Its market cap has decreased by -22.30% in one year.
Market Cap
23.40M
Enterprise Value
24.60M
1-Year Change
-22.30%
Ranking
Category
Stock Price
0.72
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $23.40M, a decrease of -81.62%. That is a compound annual growth rate of -41.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 48.74M | 372.63% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |